glp 1 and osa Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review Biosil Post Weight Loss Support:

You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider

Know low blood sugar signs and coordinate dosing

The EC50 of GLP1 (7-36) is in the expected 2 digits pM range (25-60pM), while its metabolite shows a potency which is 4 logs lower and falls into the low M range

doi: 10.1001/jama.297.24.2716

Their low share of added value and thus low operating costs should give providers time to continue expanding their offerings with sustained viability

Sources Jiang Y, et al